Skip to main content
Journal of Ophthalmic Inflammation and Infection
Fig. 2 | Journal of Ophthalmic Inflammation and Infection

Fig. 2

From: Preventing relapse in non-infectious uveitis affecting the posterior segment of the eye – evaluating the 0.2 μg/day fluocinolone acetonide intravitreal implant (ILUVIEN®)

Fig. 2

The 0.2 μg/day FAc intravitreal implant is a polyimide polymer tube that is injected intravitreally through a modified 25-gauge needle injector. The tube contains a 3 mm core of fluocinolone acetonide that is designed to release the corticosteroid within the vitreous for up to 36 months

Back to article page